JENNIFER WEST: Open Payments
NPI 1043443880 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,355 in 190 payments from 13 companies in 2025. Trend: 2023 $1,776 · 2024 $1,762 · 2025 $2,355
Food & beverage: $2,255Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 88 | $969 |
| Incyte Corporation | 25 | $279 |
| GENZYME CORPORATION | 12 | $200 |
| ABBVIE INC. | 13 | $187 |
| Lilly USA, LLC | 9 | $181 |
| Arcutis Biotherapeutics, Inc. | 17 | $158 |
| MAYNE PHARMA COMMERCIAL LLC | 11 | $133 |
| Regeneron Healthcare Solutions, Inc. | 2 | $58 |
| Amgen Inc. | 3 | $55 |
| Novartis Pharmaceuticals Corporation | 3 | $52 |
Products named: TREMFYA, OPZELURA, DUPIXENT, EBGLYSS, RINVOQ, Zoryve, AXERT, OTEZLA.
Industry payments across PA — which companies pay providers there.
